Company intelligence / Profile preview

3i Group

London, England, United Kingdom3i.com ↗

Ownership: Private
Employees: ~223
Development stage: Commercial

Overview

3i Group is an international investment firm specializing in private equity and infrastructure. It invests in mid-market companies across sectors including healthcare, consumer, industrial technology, and more. In healthcare and life sciences, it backs several active companies such as ten23 health—a CDMO focused on biopharmaceutical injectables—and has created platforms in single-use bioprocessing for the biopharma sector[2][5][8][10]. However, 3i does not itself conduct drug discovery or clinical development.

Industry: Investors

Beyond the preview

Go deeper on 3i Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3i Group.

Explore the full profile